Section 246-945-051 - Schedule IThe commission finds that the following substances have high potential for abuse and have no accepted medical use in treatment in the United States or that they lack accepted safety for use in treatment under medical supervision. In addition to the substances scheduled in RCW 69.50.204 the commission places each of the following controlled substances by whatever official name, common or usual name, chemical name, or brand name in Schedule I.
(1) Opiates. Unless specifically exempted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation: (a) (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); some other names: Acetyl fentanyl;(b) 3,4-Dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers; some other names: U-47700;(c) 3,4-dichloro-N-[(1-dimethylamino) cyclohexyl-methyl]benzamide; some other names: AH-7921;(e) N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers; some other names: Acryl fentanyl and acry-loylfentanyl;(f) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers; some other names: Butyryl fentanyl;(g) N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-car-boxamide, its isomers, esters, ethers, salts, and salts of iso-mers, esters, and ethers; some other names: Furanyl fentanyl;(h) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) isobutyramide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers; some other names: 4-fluoroisobu-tyryl fentanyl and para-fluoroisobutyryl fentanyl;(i) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers; some other names: Beta-hydroxythiofentanyl; and(2) Opium derivatives. Unless specifically exempted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: Methylhy-dromorphine.(3) Hallucinogenic substances. Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation. For purposes of this subsection only, the term "isomer" includes the optical, position, and geometric isomers: (a) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one; some other names: Butylone and bk-MBDB;(b) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one; some other names: Pentylone and bk-MBDP;(c) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine; some other names: 2C-P;(d) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine; some other names: 2C-E;(e) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine; some other names: 2C-D;(f) 2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine; some other names: 2C-N;(g) 2-(2,5-Dimethoxyphenyl)ethanamine; some other names: 2C-H;(h) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxy-benzyl)ethanamine; some other names: 25B-NBOMe and 2C-B-NBOMe;(i) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine; some other names: 2C-C;(j) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxy-benzyl)ethanamine; some other names: 25C-NBOMe and 2C-C-NBOMe;(k) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine; some other names: 2C-I;(l) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxyben-zyl)ethanamine; some other names: 25I-NBOMe and 2C-I-NBOMe;(m) 2,5-dimethoxyamphetamine; some other names: 2,5-dimethoxy-alpha-methylphenethylamine and 2,5-DMA;(n) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine; some other names: 2C-T-2;(o) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethana-mine; some other names: 2C-T-4;(p) 3,4-Methylenedioxymethcathinone; some other names: Methylone;(q) 3,4-methylenedioxy-N-ethylamphetamine; some other names: N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, and MDEA;(r) 3,4-Methylenedioxypyrovalerone; some other names: MDPV;(s) 4-bromo-2,5-dimethoxy-amphetamine: Some trade or other names: 4-bromo-2,5-dimethoxy-alpha-methyl-phenethylamine; some other names: 4-bromo-2,5-DMA;(t) 4-methoxyamphetamine; some other names: 4-methoxy-alpha-methylphenethylamine; paramethoxyam-phetamine, PMA;(u) 4-methyl-2,5-diamethoxyamphetamine;(v) 4-methyl-2,5-dimethoxy-amphetamine; some other names: 4-methyl-2,5-dimethoxy-alpha-methylphenethyl-amine; "DOM"; and "STP";(w) 4-Methylmethcathinone; some other names: Mephedrone;(x) 5-methoxy-N,N-dimethyltryptamine; some other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole and 5-MeO-DMT;(y) Alpha-ethyltryptamine; some other names: Etryptamine; monase; a-ethyl-1H-indole-3-ethanamine; 3-(2-ami-nobutyl) indole; a-ET; and AET;(z) Beta-keto-N-Methylbenzodioxolylpropylamine; some other names: bk-MBDB and Butylone;(aa) Ethylamine analog of phencyclidine; some other names: N-ethyl-1phenylcyclohexalymine, (1-phenylcyclo-hexyl) ethylamine; N-(1-phenylcyclohexyl)ethylamine; cyclohexamine; and PCE;(bb) Ibogaine; some other names: 7-Ethyl-6,6 beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole; and Tabernanthe iboga;(cc) Marijuana Extract - Meaning an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant;(dd) N-hydroxy-3,4-methylenedioxyamphetamine; some other names: N-hydroxy-alpha-methyl-3,4(methylene-dioxy)-phenethylamine; and N-hydroxy MDA;(ee) Pyrrolidine analog of phencyclidine; some other names: 1-(1-phenylcyclohexyl)pyrrolidine; PCPy; and PHP;(ff) Thiophene analog of phencyclidine; some other names: 1-[1-(2-thienyl)-cyclohexyl]-pipendine; 2-thienylan-alog of phencyclidine; TPCP; TCP.(4) Stimulants. Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers: (a) Cathinone; also known as 2-amino-1-phenyl-1-pro-panone, alpha-aminopropiophenone; 2-aminopropiophe-none; and norephedrone;(b)N,N-dimethylamphetamine; some other names: N,N-alpha-trimethyl-benzeneethanamine; and N,N-alpha-trimeth-ylphenethylene.(5) Cannabimimetic agents and synthetic cannabinoids. Any of the following synthetic cannabimimetics and cannabinoids, commonly known as spice, their salts, isomers, and salts of isomers, unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quality of the following substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (a) (1-pentyl-1H-indol-3-yl) (2,2,3,3-tetramethylcyclo-propyl)methanone; some other names: UR-144;(b) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone, its optical, positional, and geometric isomers, salts, and salts of isomers; some other names: THJ-2201;(c) [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetram ethylcyclopropyl)methanone; some other names: 5-fluoro-UR-144 and XLR11;(d) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole; some other names: AM2201;(e) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole; some other names: AM694;(f) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole; some other names: JWH-200;(g) 1-butyl-3-(1-naphthoyl)indole; some other names: JWH-073;(h) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl) indole; some other names: SR-18 and RCS-8;(i) 1-hexyl-3-(1-naphthoyl)indole; some other names: JWH-019;(j) 1-pentyl-3-(1-naphthoyl)indole; some other names: JWH-018 and AM678;(k) 1-pentyl-3-(2-chlorophenylacetyl)indole; some other names: JWH-203;(l) 1-pentyl-3-(2-methoxyphenylacetyl)indole; some other names: JWH-250;(m) 1-pentyl-3-(4-chloro-1-naphthoyl)indole; some other names: JWH-398;(n) 1-pentyl-3-(4-methyl-1-naphthoyl)indole; some other names: JWH-122;(o) 1-pentyl-3-[(4-methoxy)-benzoyl]indole; some other names: SR-19 and RCS-4;(p) 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole; some other names: JWH-081;(q) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclo-hexyl]-phenol; some other names: CP-47,497;(r) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclo-hexyl]-phenol; some other names: Cannabicyclohexanol or CP-47,497 C8-homolog;(s) Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carbox-amido)-3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers; some other names: MDMB-FUBINACA;(t) Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carbox-amido)-3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers; some other names: 5F-ADB; and 5F-MDMB-PINACA;(u) Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carbox-amido)-3-methylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers; some other names: 5F-AMB;(v) Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-car-boxamido)-3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts, and salts of isomers; some other names: MDMB-CHMICA; and MMB-CHMINACA;(w) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carbox-amide; some other names: APINACA and AKB48;(x) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-flu-orobenzyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers; some other names: ADB-FUBINACA;(y) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers; some other names: MAB-CHMINACA; and ADB-CHMI-NACA;(z) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pen-tyl-1H-indazole-3-carboxamide; some other names: ADB-PINACA;(aa) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluo-robenzyl)-1H-indazole-3-carboxamide; some other names: AB-FUBINACA;(bb) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclo-hexylmethyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers; some other names: AB-CHMINACA;(cc) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers; some other names: AB-PINACA;(dd) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-inda-zole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers; some other names: 5F-APINACA; and 5F-AKB48;(ee) Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-car-boxylate; some other names: 5-fluoro-PB-22; and 5F-PB-22;(ff) Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate; some other names: PB-22; and QUPIC.(6) Synthetic cathinones, commonly known as bath salts, and its derivatives. Unless specifically exempted or listed in another schedule, any of the following synthetic cathinone and derivatives, their salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific designation: (a) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one; some other names: Naphyrone;(b) 2-(methylamino)-1-phenylpentan-1-one; some other names: Pentedrone;(c) 3-fluoro-N-methylcathinone; some other names: 3-FMC;(d) 4-fluoro-N-methylcathinone; some other names: 4-FMC and flephedrone;(e) 4-methyl-alpha-pyrrolidinopropiophenone; some other names: 4-MePPP;(f) 4-methyl-N-ethylcathinone; some other names: 4-MEC;(g) Alpha-pyrrolidinobutiophenone; some other names: Alpha-PBP;(h) Alpha-pyrrolidinopentiophenone; some other names: Alpha-PVP;(i) N-Ethylpentylone, its optical, positional, and geometric isomers, salts, and salts of isomers; some other names: 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one).Wash. Admin. Code § 246-945-051
Adopted by WSR 20-12-072, Filed 6/1/2020, effective 7/1/2020, and 3/1/2021Reviser's note: The typographical error in the above section occurred in the copy filed by the agency and appears in the Register pursuant to the requirements of RCW 34.08.040.